Advances in Cancer Research: Current and Future Diagnostic and Therapeutic Strategies
Biosensors · 16.02.2024 · 14 (2) · 100
DOI: 10.3390/bios14020100 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 16.02.2024. Verfasst von Xiaohui Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, Chin…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Neoplasms, Unknown Primary, Fluorine Radioisotopes. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Primary Research & Development Plan of Jiangsu Province, ISF-NSFC Joint Research Program.
Abstract (Originalsprache)
Cancers of unknown primary (CUP) exhibit significant cellular heterogeneity and malignancy, which poses significant challenges for diagnosis and treatment. Recent years have seen deeper insights into the imaging, pathology, and genetic characteristics of CUP, driven by interdisciplinary collaboration and the evolution of diagnostic and therapeutic strategies. However, due to their insidious onset, lack of evidence-based medicine, and limited clinical understanding, diagnosing and treating CUP remain a significant challenge. To inspire more creative and fantastic research, herein, we report and highlight recent advances in the diagnosis and therapeutic strategies of CUP. Specifically, we discuss advanced diagnostic technologies, including 12-deoxy-2-[fluorine-18]fluoro-D-glucose integrated with computed tomography (18F-FDG PET/CT) or 68Ga-FAPI (fibroblast activation protein inhibitor) PET/CT, liquid biopsy, molecular diagnostics, self-assembling nanotechnology, and artificial intelligence (AI). In particular, the discussion will extend to the effective treatment techniques currently available, such as targeted therapies, immunotherapies, and bio-nanotechnology-based therapeutics. Finally, a novel perspective on the challenges and directions for future CUP diagnostic and therapeutic strategies is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 210096, China.
ORCID-Profile: Hui Jiang
Förderung
- National Natural Science Foundation of China
- Primary Research & Development Plan of Jiangsu Province
- ISF-NSFC Joint Research Program
- the Start-up Research Fund of Southeast University
- Primary Research & Development Plan of Jiangsu Province
- Start-up Research Fund of Southeast University
Zitieren
APA
Liu, X., Jiang, H., & Wang, X. (2024). Advances in Cancer Research: Current and Future Diagnostic and Therapeutic Strategies. Biosensors, 14(2), 100. https://doi.org/10.3390/bios14020100
Vancouver
Liu X, Jiang H, Wang X. Advances in Cancer Research: Current and Future Diagnostic and Therapeutic Strategies. Biosensors. 2024;14(2):100. doi:10.3390/bios14020100
BibTeX
@article{Liu2024,
author = {Liu, Xiaohui and Jiang, Hui and Wang, Xuemei},
title = {Advances in Cancer Research: Current and Future Diagnostic and Therapeutic Strategies},
journal = {Biosensors},
year = {2024},
volume = {14},
number = {2},
pages = {100},
doi = {10.3390/bios14020100}
}
EUVIMED